Clinical Trial
[Bencyclane in stage II arterial occlusive disease. Results of a controlled study]
[Article in
German]
- PMID: 2695437
Item in Clipboard
Clinical Trial
[Bencyclane in stage II arterial occlusive disease. Results of a controlled study]
[Article in
German]
Fortschr Med.
.
Abstract
In a single-center, double-blind, randomized study, 19 patients with peripheral arterial occlusive disease stage II Fontaine were treated with bencyclan, and a further 19 patients with buflomedil for 10 weeks after a wash-out phase of 2 weeks. Both groups showed a significant increase in painfree and total walking distances. No significant difference was found between the two groups.
Similar articles
-
Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of Angiology.Vasa. 1992;21(4):333-43. Vasa. 1992. PMID: 1485465 English, German. No abstract available.
-
[Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].J Mal Vasc. 1995;20(1):21-7. J Mal Vasc. 1995. PMID: 7745355 Clinical Trial. French.
-
[Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].Clin Ter. 1984 Jul 15;110(1):29-36. Clin Ter. 1984. PMID: 6237843 Clinical Trial. Italian. No abstract available.
-
Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.Int Angiol. 1992 Jul-Sep;11(3):204-10. Int Angiol. 1992. PMID: 1460355 Review.
-
[Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].Z Arztl Fortbild Qualitatssich. 1999 Nov;93(9):639-44. Z Arztl Fortbild Qualitatssich. 1999. PMID: 10666827 Review. German.